Last reviewed · How we verify
NCT06908967
A Performance Study Comparing the EyeMirage (Test Device) to Standard of Care (Reference Device) in Patients 18 to 65 Years of Age Undergoing Standard Eye Examinations Such as Visual Acuity, Visual Field, Color Vision, and Self-Paced Saccade for Various Conditions
NA trial testing EyeMirage device in Visual Function in 160 participants. Completed in 24 February 2026.
24 February 2026
Quick facts
| Lead sponsor | Neuroptek Corporation Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | single |
| Primary purpose | screening |
| Enrollment | 160 |
| Start date | 13 June 2025 |
| Primary completion | 24 February 2026 |
| Estimated completion | 24 February 2026 |
| Sites | 4 locations across Canada |
Drugs / interventions tested
- EyeMirage device
Conditions studied
- Visual Function — all drugs for Visual Function →
Sponsor
Neuroptek Corporation Inc.
Who can join
Adults 18 to 65, any sex, with Visual Function. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study will assess the effectiveness and accuracy of results of a new device for eye function testing. This will be done by comparing results of four eye tests that are done through the current standard used in eye clinics and that of this new device. Participants of this study will undergo the four eye tests using both the new device and the standard of care devices. The study will be done in one visit to the eye clinic. Thirty days after the eye tests were done, participants will be called by the clinic for a general follow-up and to discuss any problems, if needed.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06908967
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Visual Function
Currently open trials in the same condition.
- NCT07081139 — Visual Function Screening System With Special Needs Children and Typical Preschoolers · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06908967 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Neuroptek Corporation Inc.
- Last refreshed: 12 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06908967.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing